Health Insurance Bureau: All localities should follow the procedures to include nucleic acid testing and other items in health insurance

Provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps Medical Security Bureau:
To implement the central response to the epidemic leadership group meeting deployment and "
response to the new crown pneumonia epidemic joint prevention and control mechanism on the new crown pneumonia epidemic normalization and control work guidance", further enhance the new Coronavirus detection capacity, orderly guidance to reduce the high detection costs, support the realization of "due diligence, willing to check", to help normal prevention and control and resumption of work and re-learning, is doing a good job of new coronavirus detection of the hanging network procurement, price management and medical insurance payment work notice as follows.(i) generally carry out public online procurement. All over the pharmaceutical centralized procurement agencies to do a good job of the new crown virus detection reagents hanging network work, improve the provincial centralized procurement platform between the information sharing, price linkage mechanism. Public medical institutions shall purchase new coronavirus testing reagents from sunshine, a centralized procurement platform for provincial drug supplies in their provinces.
(ii) encourage centralized procurement. The provincial and regional health insurance departments are encouraged to actively explore the centralized procurement of new coronavirus detection reagents, select enterprises with higher product quality, strong production capacity, stable supply and good integrity, and promote price return to a reasonable level through competition. The centralized procurement of new coronavirus testing reagents should, in principle, be selected to ensure supply stability. For areas with large-scale population detection needs, priority should be given to centralized procurement. Conditional areas actively carry out centralized volume procurement.(i) the test item does not "by disease project". In principle, no distinction is made between pathogens or operational steps of the new nucleic acid, antibody detection price items, Class A infectious diseases or according to the law according to Class A management of infectious diseases related inspection, such as the risk is difficult, high protection requirements, can be based on the prevailing price items to formulate a unified collection policy. Public medical institutions for the new coronavirus nucleic acid, antibody testing, can directly implement the existing charging policy, no need to apply for new price items.
(ii) a single temporary project should reflect the "separation of technical consumption". It is necessary to set up a single temporary project to meet the demand for new coronavirus detection charges in public medical institutions, and to encourage all localities to set up projects in the form of "separation of technical consumption". Samples of nucleic acid and antibody testing, processing, marking, recycling, issuing diagnostic results, and consumables such as nasopharyngeal swabs should be combined as the pricing of medical service price items;On the basis of comprehensive consideration of the needs of the prevention and control of new coronavirus pneumonia and the ability of the regional health insurance fund to pay, nucleic acids, antibody testing projects and related consumables for the new coronavirus should be included in the list of provincial medical insurance treatment projects according to procedures, and payment conditions should be determined simultaneously.
health insurance departments should attach great importance to this work, in the work encountered major problems and situations, please report to the State Health Insurance Administration in a timely manner.
office of the National
Health Insurance Administration, June 16, 2020